FNC
CVS icon

First National Corp’s CVS Health CVS Stock Holding History

First National Corp’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,681
Closed -$291K – 156
2024
Q1 		$291K Hold
3,681
– – 0.07% 134
2023
Q4 		$291K Sell
3,681
-193
-5% -$13.7K 0.07% 134
2023
Q3 		$270K Buy
3,874
+173
+5% +$12.3K 0.07% 131
2023
Q2 		$256K Buy
3,701
+466
+14% +$33.2K 0.06% 140
2023
Q1 		$240K Buy
3,235
+26
+0.8% +$2.18K 0.06% 150
2022
Q4 		$299K Buy
3,209
+2
+0.1% +$193 0.07% 135
2022
Q3 		$306K Sell
3,207
-90
-3% -$8.91K 0.08% 128
2022
Q2 		$305K Sell
3,297
-210
-6% -$20.5K 0.08% 130
2022
Q1 		$355K Buy
3,507
+26
+0.7% +$2.73K 0.08% 130
2021
Q4 		$359K Buy
3,481
+440
+14% +$40.7K 0.08% 125
2021
Q3 		$258K Buy
+3,041
New +$255K 0.06% 141
2019
Q2 		– Sell
-268
Closed -$14K – 203
2019
Q1 		$14K Sell
268
-340
-56% -$21K 0.01% 309
2018
Q4 		$40K Buy
+608
New +$45.4K 0.02% 234

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First National Corp's CVS Position: Q2 2024 in Review

First National Corp sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,681 shares — an estimated $291K sold.

First National Corp first reported a position in CVS in Q4 2018 and held it in 13 quarters. The position peaked at $359K in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • First National Corp reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • First National Corp sold 3,681 CVS Health shares in Q2 2024, an estimated $291K.
  • First National Corp first reported a position in CVS Health in Q4 2018 and held it in 13 quarters.
  • First National Corp's CVS Health position peaked at $359K in Q4 2021.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on First National Corp's 13F filing for Q2 2024, filed 12 Jul 2024.